Gene-specific cancer risks in female Lynch syndrome carriers: A copula-based meta-analysis

MLH1, MSH2, MSH6, PMS2 (MMR genes)

Copula-based meta-analysis of cumulative cancer risks (colorectal, endometrial, ovarian, urinary, gastric) by MMR gene in female Lynch syndrome carriers; integration of inter-organ correlation data

Copula-based meta-analysis of cumulative cancer risks by MMR gene in female Lynch syndrome carriers. The analysis provides gene-specific estimates (MLH1, MSH2, MSH6, PMS2) for colorectal, endometrial, ovarian, upper urinary tract and gastric cancers. The copula method integrates correlations between risks of different organs (risk of a second primary cancer), going beyond standard survival methods.

Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.

These data update gene-specific penetrance estimates in female Lynch carriers, directly applicable to personalized surveillance protocols (colonoscopy, gynecological surveillance). The use of the copula method is a methodological advance for multi-organ penetrance studies.

updated gene-specific penetrance data +3; copula meta-analysis (innovative methodology) +2; direct impact on surveillance protocols +2